Vaccine Contract Manufacturing Market is estimated to be US$ 6.50 Billion by 2032 with a CAGR of 10.2% over the forecast period
globenewswire.com
business
2022-10-20 13:01:00

Covina, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Vaccine Contract Manufacturing Market accounted for US$ 2.5 billion in 2022 and is estimated to be US$ 6.50 by 2032 and is anticipated to register a CAGR of 10.2%. Manufacturing vaccine includes workflow of upstream and downstream processes. Upstream process includes, virus production and cell growth. Downstream process includes, purification, clarification and recovery of viruses. Viral infection causes severe illness and millions of deaths all around the world.
